Last Updated : July 24, 2024
Details
Last Updated : July 24, 2024
Details
Program Updates
1. Working Toward Target Zero: Expanding Our Rolling Review Pilot Process
Canada’s Drug Agency is taking a new step to improve the timeliness of patient access to new drugs. The action supports our ambitious Target Zero campaign — an initiative that aims to achieve zero days between Health Canada’s regulatory approval of a drug and our reimbursement recommendation to participating public drug plans.
Last Updated : July 25, 2024
Details
Last Updated : July 24, 2024
Details
| Call for patient/clinician/industry input open | 11-Jul-24 |
|---|---|
| Call for patient/clinician/industry input closed | 30-Aug-24 |
| Submission received | 04-Jul-24 |
| Review initiated | 05-Jul-24 |
| Expert committee meeting (initial) | 21-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 12-Dec-24 |
| End of feedback period | 03-Jan-25 |
| Final recommendation posted | 04-Feb-25 |
| CADTH review report(s) posted | 29-Jan-25 |
Last Updated : February 10, 2025
Details
| Call for patient/clinician input open | 04-Jul-24 |
|---|---|
| Call for patient/clinician input closed | 30-Aug-24 |
| Submission received | 15-Aug-24 |
| Submission accepted | 29-Aug-24 |
| Review initiated | 30-Aug-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 18-Nov-24 |
| Deadline for sponsors comments | 27-Nov-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 19-Dec-24 |
| Expert committee meeting (initial) | 08-Jan-25 |
| Draft recommendation issued to sponsor | 29-Apr-25 |
| Clarification: - pERC recommendation held pending receipt of NOC and evaluation of the finalized submission requirements. . | |
| Draft recommendation posted for stakeholder feedback | 08-May-25 |
| End of feedback period | 23-May-25 |
| Final recommendation issued to sponsor and drug plans | 06-Jun-25 |
| Final recommendation posted | 24-Jun-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 20-Jun-25 |
| CDA-AMC review report(s) posted | - |
Last Updated : June 24, 2025
Details
| Call for patient/clinician input open | July 04, 2024 |
|---|---|
| Call for patient/clinician input closed | August 23, 2024 |
| Submission received | August 15, 2024 |
| Submission accepted | August 29, 2024 |
| Review initiated | August 30, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | November 28, 2024 |
| Deadline for sponsors comments | December 09, 2024 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | January 10, 2025 |
| Expert committee meeting (initial) | January 22, 2025 |
| Draft recommendation issued to sponsor | February 04, 2025 |
| Draft recommendation posted for stakeholder feedback | February 13, 2025 |
| End of feedback period | February 28, 2025 |
| Final recommendation issued to sponsor and drug plans | March 12, 2025 |
| Final recommendation posted | March 31, 2025 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | March 27, 2025 |
| CDA-AMC review report(s) posted | July 24, 2025 |
Last Updated : July 29, 2025
Details
| Call for patient/clinician input open | 03-Jul-24 |
|---|---|
| Call for patient/clinician input closed | 23-Aug-24 |
| Submission received | 14-Aug-24 |
| Submission accepted | 28-Aug-24 |
| Review initiated | 29-Aug-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 15-Nov-24 |
| Deadline for sponsors comments | 26-Nov-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 19-Dec-24 |
| Expert committee meeting (initial) | 08-Jan-25 |
| Draft recommendation issued to sponsor | 21-Jan-25 |
| Draft recommendation posted for stakeholder feedback | 30-Jan-25 |
| End of feedback period | 13-Feb-25 |
| Final recommendation issued to sponsor and drug plans | 28-Feb-25 |
| Final recommendation posted | 19-Mar-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 17-Mar-25 |
| CDA-AMC review report(s) posted | 27-Jun-25 |
Last Updated : June 27, 2025
Details
| Submission received | 11-Jul-24 |
|---|---|
| Review initiated | 12-Jul-24 |
| Expert committee meeting (initial) | 21-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 12-Dec-24 |
| End of feedback period | 03-Jan-25 |
| Final recommendation posted | 04-Feb-25 |
| CADTH review report(s) posted | 29-Jan-25 |
Last Updated : February 10, 2025
Details
| Submission received | 11-Jul-24 |
|---|---|
| Review initiated | 12-Jul-24 |
| Expert committee meeting (initial) | 21-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 12-Dec-24 |
| End of feedback period | 03-Jan-25 |
| Final recommendation posted | 04-Feb-25 |
| CADTH review report(s) posted | 29-Jan-25 |
Last Updated : February 10, 2025